Why the study?
Consumption of sugar-sweetened beverages is associated with type 2 diabetes and cardiovascular disease, but an updated and comprehensive assessment of the global attributable burden remains scarce.
Does sugar-sweetened beverage consumption increase the incidence of type 2 diabetes and cardiovascular disease globally?
Does sugar-sweetened beverage consumption increase the incidence of type 2 diabetes and cardiovascular disease globally?
Sugar-sweetened beverage consumption is responsible for a substantial and growing global burden of incident type 2 diabetes and cardiovascular disease, particularly in Latin America, the Caribbean, and sub-Saharan Africa.
Answers are grounded in this paper and cite their sources.
SSB-attributable T2D/CVD burdens persist globally; extends observational estimates while leaving causal effects and policy impacts open.
The consumption of sugar-sweetened beverages (SSBs) is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). However, an updated and comprehensive assessment of the global burden attributable to SSBs remains scarce. Here we estimated SSB-attributable T2D and CVD burdens across 184 countries in 1990 and 2020 globally, regionally and nationally, incorporating data from the Global Dietary Database, jointly stratified by age, sex, educational attainment and urbanicity. In 2020, 2.2 million (95% uncertainty interval 2.0-2.3) new T2D cases and 1.2 million (95% uncertainty interval 1.1-1.3) new CVD cases were attributable to SSBs worldwide, representing 9.8% and 3.1%, respectively, of all incident cases. Globally, proportional SSB-attributable burdens were higher among men versus women, younger versus older adults, higher- versus lower-educated adults, and adults in urban versus rural areas. By world region, the highest SSB-attributable percentage burdens were in Latin America and the Caribbean (T2D: 24.4%; CVD: 11.3%) and sub-Saharan Africa (T2D: 21.5%; CVD: 10.5%). From 1990 to 2020, the largest proportional increases in SSB-attributable incident T2D and CVD cases were in sub-Saharan Africa (+8.8% and +4.4%, respectively). Our study highlights the countries and subpopulations most affected by cardiometabolic disease associated with SSB consumption, assisting in shaping effective policies and interventions to reduce these burdens globally.
No takes yet. Share an insight, caveat, or question.
Lara-Castor et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: